May 29, 2018
Funded by the Norwegian Research Council
Klebsiella pneumoniae has emerged as a high-risk human pathogen due to its virulence and increasing levels of antimicrobial resistance (AMR), and has by WHO been defined as one of the multidrug resistant (MDR) bacteria posing the greatest threat ...
Members of the AMR group at Stavanger University Hospital and Holtlab have a new preprint of their work on a new carbapenemase producing Klebsiella pneumoniae clone, ST307. Click to read the abstract and access the full article.